Skip to main content

and
  1. No Access

    Article

    Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy

    Our previously published study showed promising results of autologous stem cell transplantation (ASCT) in patients with primary resistant Hodgkin's disease (HD). Probabilities of overall survival (OS) and prog...

    J Czyz, R Szydlo, W Knopinska-Posluszny, A Hellmann in Bone Marrow Transplantation (2004)

  2. No Access

    Article

    High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group

    We analysed the treatment outcome of primary refractory HD patients managed with high-dose chemotherapy and haematopoietic cell transplantation. Data of 65 adult patients who underwent HDC/ASCT in nine Polish ...

    J Czyż, A Hellmann, R Dziadziuszko, J Hansz, J Goździk in Bone Marrow Transplantation (2002)